Udit Batra
With 20+ years in pharma and life sciences, new CEO Udit Batra aims to achieve 22-24% earnings growth via strategic investments and targeted small acquisitions.
Former peers consistently commend Batra’s keen analytical skills and leadership, confident he will guide the company through its upcoming growth stage.
Batra’s history of successful turnarounds at Millipore and Novartis, combined with his knowledge of Waters’ customers, equips him well for this leadership role.
By submitting this form, you are agreeing to ManagementTrack’s Privacy Policy. You can choose to opt out of marketing or advertising emails using the ‘unsubscibe’ link included in our emails.
The best
The best
The best
Our investigative journalists interview the top former colleagues of the CEOs you care about.
Our former buysider analysts summarize the key strengths & weaknesses, past successes & failures, and ability to drive value going forward.
You get access to the actual anonymized transcripts and insights.